Lumexa Imaging Holdings, Inc. Common Stock

LMRINASDAQHealthcare● Active

$8.13

$-0.37(-4.35%)

Market Cap$781136376

P/E Ratio—

52W High$19.45

52W Low$6.45

Avg Volume1.0M

Open$8.59

Beta2.18

Free Cash Flow Financials Revenue

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

LMRI · free cash flow · updated Jun 8, 2026

Core FCF metrics

LMRI · FCF · TTM · margin & CAGR

Free cash flow was −$6.4M for FY2025 (fiscal year ending 2025-12-31), down 149.4% year-over-year The FCF margin was -0.6%.

FY2025 Free Cash Flow−$6.4M▼ -149.4% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

FCF Margin-0.6%−$6.4M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

LMRI · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$17.1M(23M)−$6.4M▼ 149.4%-0.6%

FY2024$40.7M(28M)$13.0M▼ 4.1%1.4%

FY2023$37.5M(24M)$13.5M—1.4%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

LMRI · P/FCF · FCF yield · FCF per share

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

LMRI · cash flow statement · operating / investing / financing

For FY2025, Lumexa Imaging Holdings, Inc. Common Stock generated $17.1M in operating cash flow and spent 23M in capital expenditures, yielding −$6.4M in free cash flow.

Operating Activities

+$17.1M

Cash from core business operations

2025-12-31

Investing Activities

−$21.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$36.6M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($17.1M) − |CapEx| (23M) = FCF (−$6.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

LMRI vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Lumexa Imaging Holdings, Inc. Common StockYOU

LMRI

−$6.4M-149.4%-0.6%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) reported free cash flow of −$6.4M for FY2025 (fiscal year ending 2025-12-31), down 149.4% year-over-year. The FCF margin was -0.6%.

Based on available data, Lumexa Imaging Holdings, Inc. Common Stock has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $13.5M in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

LMRI free cash flow · 8 questions

Lumexa Imaging Holdings, Inc. Common Stock free cash flow was −$6.4M for FY2025, down 149.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at —.

LMRI free cash flowLMRI FCFLMRI FCF 2025LMRI free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Lumexa Imaging Holdings, Inc. Common Stock · Lumexa Imaging Holdings, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026